Photo of Amarnath Natarajan

View Scopus Profile

Amarnath Natarajan, PhD

 https://orcid.org/0000-0001-5067-0203
  • 1554 Citations
  • 24 h-Index
20002020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Amarnath Natarajan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Development of Quinoxaline Based IKKbeta Inhibitors for Kras Driven Cancers

Natarajan, A.

National Institutes of Health

5/9/16 → 4/30/21

Project: Research project

    • Phosphorylated Form of Activated IKKbeta and Pancreatic Cancer

    Natarajan, A.

    National Institutes of Health

    1/1/14 → 12/31/16

    Project: Research project

    • pBACH1 binding site on BRCT(BRCA1): A novel approach to cancer therapeutics

    Natarajan, A.

    National Institutes of Health

    9/8/08 → 7/31/14

    Project: Research project

    • HTS to Identify Small Molecule Inhibitors of Phospho-Specific Protein-Protein Int

    Natarajan, A.

    National Institutes of Health

    6/1/07 → 5/31/09

    Project: Research project

    • Research Output

    EHD1 and RUSC2 control basal epidermal growth factor receptor cell surface expression and recycling

    Tom, E. C., Mushtaq, I., Mohapatra, B. C., Luan, H., Bhat, A. M., Zutshi, N., Chakraborty, S., Islam, N., Arya, P., Bielecki, T. A., Iseka, F. M., Bhattacharyya, S., Cypher, L. R., Goetz, B. T., Negi, S. K., Storck, M. D., Rana, S., Barnekow, A., Singh, P. K., Ying, G. & 4 others, Guda, C., Natarajan, A., Band, V. & Banda, H., Apr 1 2020, In : Molecular and cellular biology. 40, 7, e00434.

    Research output: Contribution to journal › Article

    • 2 Scopus citations

    Erratum: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy (Oncotarget (2018) 9 (5216-5232) DOI: 10.18632/oncotarget.23749)

    Robb, C. M., Kour, S., Contreras, J. I., Agarwal, E., Barger, C. J., Rana, S., Sonawane, Y., Neilsen, B. K., Taylor, M., Kizhake, S., Thakare, R. N., Chowdhury, S., Wang, J., Black, J. D., Hollingsworth, M. A., Brattain, M. G. & Natarajan, A., Jun 23 2020, In : Oncotarget. 11, 25, p. 2462-2463 2 p.

    Research output: Contribution to journal › Comment/debate

    Open Access

    • Symbiotic prodrugs (SymProDs) dual targeting of NFkappaB and CDK

    Rana, S., Kour, S., Sonawane, Y. A., Robb, C. M., Contreras, J. I., Kizhake, S., Zahid, M., Karpf, A. R. & Natarajan, A., Aug 1 2020, In : Chemical Biology and Drug Design. 96, 2, p. 773-784 12 p.

    Research output: Contribution to journal › Article

    • A mitotic CDK5-PP4 phospho-signaling cascade primes 53BP1 for DNA repair in G1

    Zheng, X. F., Acharya, S. S., Choe, K. N., Nikhil, K., Adelmant, G., Satapathy, S. R., Sharma, S., Viccaro, K., Rana, S., Natarajan, A., Sicinski, P., Marto, J. A., Shah, K. & Chowdhury, D., Dec 1 2019, In : Nature communications. 10, 1, 4252.

    Research output: Contribution to journal › Article

    Open Access
    • 3 Scopus citations

    A simple fluorescent assay for the discovery of protein-protein interaction inhibitors

    Al-Mugotir, M., Kolar, C., Vance, K., Kelly, D. L., Natarajan, A. & Borgstahl, G. E. O., Mar 15 2019, In : Analytical Biochemistry. 569, p. 46-52 7 p.

    Research output: Contribution to journal › Article

    • 2 Scopus citations